Insights from Sandoz CEO Richard Saynor on Ozempic, Big Pharma Struggles, and Political Influences

Insights from Sandoz CEO Richard Saynor on Ozempic, Big Pharma Struggles, and Political Influences
3 days ago

In a candid conversation, Richard Saynor, CEO of Sandoz, provided a deep dive into the complexities surrounding the pharmaceutical landscape, including the rising prominence of Ozempic, challenges facing the industry, and the influence of political figures such as Donald Trump. Saynor’s insights shed light on the evolving narratives within Big Pharma and the implications for patients, healthcare, and future drug development.

Continue reading
Activist Investor Starboard Value Makes a Bold Move with a $1 Billion Stake in Pharmaceutical Giant Pfizer

Activist Investor Starboard Value Makes a Bold Move with a $1 Billion Stake in Pharmaceutical Giant Pfizer
3 months ago

In a significant financial maneuver, Starboard Value LP, a prominent activist investment firm, has acquired a substantial $1 billion stake in the global pharmaceutical behemoth Pfizer Inc. This strategic investment marks an assertive push by Starboard into the healthcare sector, aiming to influence the company's direction and potentially unlock shareholder value.

Continue reading